英國國家生物制品檢定所（National Institute for Biological Standards and Control，NIBSC）

　　英國國家生物制品檢定所是WHO的一個標準品供應中心實驗室，它的核心工作是制備、保存和分發WHO用于檢測生物制品質量的標準品。NIBSC制備的流感毒株和檢測抗原、抗血清標準品，保障了各廠家順利的研究和生產。

　　NIBSC提供對投入英國市場的生物藥品的獨立測試，尤其是用于英國兒童免疫計劃的疫苗；它同時也是歐盟控制藥品進入歐盟市場的*藥品控制實驗室（OMCL）。 如果出現不能滿足藥品存放要求或患者出現不良反應等問題，NIBSC 也可對已投入歐盟市場的產品進行檢驗。

　　NIBSC認為對 NIBSC工作的核心職能制定并維護一項既均衡而又主次分明的計劃至關重要。控制和評估生物藥品。開發和提供關鍵的生物學標準和其它參考資料。開展針對任務的研究和開發工作。

Streptokinase 00/464
Interferon Beta （Human, rDNA; CHO cell-derived; Glycosylated） 00/572
Interferon Beta Ser 17 Human, recDNA, E-coli-derived, non-glycosylated 00/574
Interferon Beta, Human, Fibroblast Cell-Derived, Glycosylated 00/576
Interleukin-17 Human rec DNA 01/420
Vascular Endothelial Growth Factor, Human rDNA derived 01/424
Botulinum Antitoxin Equine Type D 01/510
Anti-D Immunoglobulin 01/572
Thrombin, human, 2nd International Standard 01/580
Low Molecular Weight Heparin, 2nd International Standard 01/608
Blood Coagulation Factor VIII Concentrate, Human 02/122
Prekallikrein Activator （PKA）, Human 02/168
Blood Coagulation Factor XIII, Plasma, Human 1st IS 02/206
IVIG negative control for use with IVIG + anti-D 02/226
IVIG + anti-D for use with negative control IVIG 02/228
Vascular Endothelial Growth Factor 02/286
Blood Coagulation Factor V, Plasma（1st I.S.） 03/116
Thrombopoietin, human rDNA derived 03/124
Keratinocyte growth factor （KGF, FGF-7）（24-163） 03/148
Keratinocyte Growth Factor （KGF,FGF-7） 03/150
Thyroid Stimulating Hormone, recombinant 03/192
Interleukin - 18 （Human rDNA derived） 03/200
IVIG + Anti-D for use with negative control IVIG 04/132
IVIG Negative Control for use with IVIG & Anti-D 04/140
TNF-related Apoptosis-Inducing Ligand （trail）, Human, rDNA-derived 04/166
Parathyroid hormone 1-34 Recombinant, Human 04/200
Protein C Concentrate, Human 04/252
Low Molecular Weight Heparin for Molecular Weight Calibration （2nd International Standard）. 05/112
Alpha-1-Antitrypsin, plasma derived 05/162
IVIG, Anti-D and Negative Control Panel 05/242
Antithrombin Concentrate, Human 06/166
FEIBA Concentrate 1st NIBSC Working Reference Standard 06/172
Blood Coagulation Factor IX Concentrate, Human, 4th International Standard” 07/182
Blood Coagulation Factor VIIa, Concentrate, Human, 2nd International Standard” 07/228
Anti-D for assuring operator and test performance 07/304
Anti-A and Anti-B in IVIG Positive Control 07/306
Anti-A and Anti-B in IVIG Negative Control 07/308
Anti-A and anti-B in IVIG: Limit reference preparation 07/310
Blood Coagulation Factor VIII and Von Willebrand Factor in Plasma （6th I.S.） 07/316
Blood Coagulation Factors II, IX,and X Concentrate, 6th British Working Standard. 07/326
Unfractionated Heparin （6th I.S.） 07/328
Blood Coagulation Factor VIII Concentrate （8th I.S.） 07/350
Chorionic Gonadotrophin, （5th International Standard） 07/364
Streptodornase （2nd International Standard） 08/230
C1- Inhibitor, Concentrate （1st International Standard） 08/256
Anti-A and Anti-B in IVIG: Positive and Negative control panel. （2 ampoules of 07/306 and 2 ampoules of 07/308） 08/270
Follicle-Stimulating Hormone, human, recombinant, for bioassay （2nd International Standard） 08/282
Granulocyte Colony Stimulating Factor （Human, rDNA Derived）（2nd International Standard） 09/136
VWF Factor Concentrate （2nd International Standard） 09/182
Corticotrophin （ACTH）, Porcine 59/016
Serum Gonadotrophin, Equine 62/001
Lysine Vasopressin, Porcine 62/014
Renin, Porcine 65/119
Gastrin II, Porcine 66/138
Interferon, Chick 67/018
Renin, Human 68/356
Glucagon, Porcine 69/194
Angiotensin II 70/302
Angiotensin I 71/328
Corticotrophin （ACTH）, Human 74/555
Ancrod 74/581
Blood Coagulation Factor Xa, Bovine 75/595
Oxytocin 76/575
Lysine Vasopressin 77/512
Secretin 77/643
Kininogenase, Porcine 78/543
Luteinizing Hormone, Pituitary, alpha subunit 78/554
Luteinizing Hormone, Pituitary, beta subunit 78/556
Prekallikrein Activator （PKA）, Human 79/572
Growth Hormone, Human, Pituitary 80/505
Luteinizing Hormone, Human, Pituitary 80/552
Tetracosactide 80/590
Parathyroid Hormone, Human-Type, Synthetic （1-34） fragment 82/508
Parathyroid Hormone, Bovine-Type, Synthetic （1-34） fragment 82/512
Interferon Gamma （Human, Leukocyte derived） 82/587
Parathyroid Hormone, Bovine 82/632
Insulin, Human 83/500
Beta Thromboglobulin, Purified Human 83/501
Plaet Factor 4 Human, Purified 83/505
Insulin, Bovine 83/511
Interferon alpha-1D, （Human rDNA derived） 83/514
Insulin, Porcine 83/515
Prolactin, Human 83/573
Follicle Stimulating Hormone, Pituitary 83/575
Prolactin, Human 84/500
Calcitonin, ASU 1-7 Eel Calcitonin Analogue （Elcatonin） 84/614
C-Reactive Protein, Human 85/506
Atrial Natriuretic Factor, Human 85/669
Interleukin-2 （Human, Jurkat derived） 86/504
Angiotensin I Human Type Synthetic 86/536
Angiotensin II 86/538
Interleukin-1 Beta （Human, rDNA derived） 86/552
Interleukin-2 （Human, rDNA derived） 86/564
Interleukin-1 alpha （Human rDNA derived） 86/632
Interleukin-1 alpha （Human, rDNA derived） 86/678
Interleukin-1 beta （Human, rDNA derived） 86/680
Inhibin, Porcine 86/690
Interferon Gamma （Human, rDNA derived） 87/586
Urokinase, High Molecular Weight 87/594
Tumour Necrosis Factor beta （Human, rDNA derived） 87/640
Tumour Necrosis Factor alpha （Mouse, rDNA derived） 88/532
Calcitonin, Eel 88/556
Erythropoietin, Human recombinant 88/574
Granulocyte Macrophage Colony Stimulating Factor （Human, rDNA derived） 88/646
Interleukin-4 （Human, rDNA derived） 88/656
Tumour Necrosis Factor alpha （Human Natural） 88/786
Macrophage Colony Stimulating Factor （CSF-1） （Human rDNA derived） 89/512
Transforming Growth Factor beta-1 （Human, rDNA derived） 89/514
Transforming Growth Factor beta-1 （Bovine） 89/516
Transforming Growth Factor beta-2 （Bovine） 89/518
Interleukin-8 （Human, rDNA derived） 89/520
Renin, Human, rec DNA 89/544
Interleukin-6 （Human, rDNA derived） 89/548
Calcitonin, Human 89/620
Interleukin-7 （Human, rDNA derived） 90/530
Interleukin-5 （Human, rDNA derived） 90/586
Transforming Growth Factor beta-2, Human, rec DNA 90/696
Basic Fibroblast Growth Factor （Human, rDNA derived） 90/712
Interleukin-3 （Human, rDNA derived） 91/510
Epidermal Growth Factor （Human, rDNA derived） 91/530
Epidermal Growth Factor （1-52） （Human, rDNA derived） 91/550
Insulin-like growth Factor 1 91/554
Inhibin A, Human, recombinant 91/624
Activin A, Human, Recombinant 91/626
Interleukin-4 （Mouse, rDNA derived） 91/656
Granulocyte Macrophage Colony Stimulating Factor （Mouse rDNA derived） 91/658
Interleukin-3 （Mouse, rDNA derived） 91/662
Interleukin-9 （Human,rDNA derived） 91/678
Stem Cell Factor （Human rDNA derived） 91/682
Follicle Stimulating Hormone, Human, recombinant 92/510
Follicle Stimulating Hormone, urofollitropin Human Urinary 92/512
Macrophage Inflammatory Protein-1 alpha （Human, rDNA derived） 92/518
Rantes （Human, rDNA derived） 92/520
Interleukin-1 Receptor Antagonist （IL-1ra） （Human, rDNA derived） 92/644
Plasminogen Activator Inhibitor-1 （PAI-1）, plasma Human 92/654
Serum amyloid A protein 92/680
Interleukin-11 （Human, rDNA derived） 92/788
Monocyte Chemoattractant Protein-1 （Human,rDNA derived） 92/794
Soluble Tumor Necrosis Receptor factor Type II （Human, rDNA derived） 93/524
Batroxobin 93/526
Nerve Growth Factor （Human, rDNA derived） 93/556
Leukaemia Inhibitory Factor （Human, rDNA derived） 93/562
Oncostatin M （Human, rDNA derived） 93/564
Interleukin-2 （Mouse, rDNA derived） 93/566
Bone morphogenetic Protein-2 （Human, rDNA derived） 93/574
Interleukin-1 beta （Mouse, rDNA derived） 93/668
Interleukin-1 alpha （Mouse, rDNA derived） 93/672
Interleukin-10 （Human rDNA derived） 93/722
Interleukin-6 （Mouse, rDNA derived） 93/730
Interleukin-7 （Mouse, rDNA derived） 93/740
Endotoxin 94/580
Interleukin-13 （Human, rDNA derived） 94/622
Ciliary Neurotrophic Factor （Human, rDNA derived） 94/684
Straphylokinase, rec （STAR） 94/718
Plaet-derived Growth Factor-BB （Human, rDNA derived） 94/728
Tissue Plasminogen Activator （tPA） Antigen in Plasma 94/730
Interferon Omega （Human, rDNA derived） 94/754
Interferon alpha （Human, leukocyte derived） 94/784
Interferon alpha Concensus Sequence （Human rDNA derived） 94/786
Interleukin-12 （Human, rDNA derived） 95/544
Interleukin-15 （Human, rDNA derived） 95/554
Single Chain Urinary-Type Plasminogen Activator （SCuPA）, （Non-Glyc） 95/564
Interferon alpha-2b （Human, rDNA derived） 95/566
Interferon Alpha n1 （Human lymphoblastoid cell derived） 95/568
Interferon alpha-1/8 （Human, rDNA derived） 95/572
Interferon Alpha n3 （Human, leukocyte derived） 95/574
Interferon alpha-2c （Human, rDNA derived） 95/580
Interferon alpha-2a （Human, rDNA derived） 95/650
Single Chain Urinary-Type Plasminogen Activator （SCuPA）, （Glyc） 95/668
Soluble Tumour Necrosis Factor Receptor Type 1, （Human, rDNA derived） 96/528
FMS-like tyrosine kinase 3 ligand （Human, rDNA derived） 96/532
Brain-derived Neurotrophic Factor （Human, rDNA derived） 96/534
Insulin-like growth Factor-II （Human rDNA derived） 96/538
Hepatocyte Growth Factor/Scatter Factor （precursor）, （Human rDNA derived） 96/556
Hepatocyte Growth Factor/Scatter Factor （Human, rDNA derived） 96/564
Luteinizing Hormone, Human, recombinant 96/602
Inhibin B, Human 96/784
Plasmin, Human 97/536
Anti-Granulocyte Macrophage Colony Stimulating Factor Serum 97/538
Blood Coagulation Factors IXa Concentrate, Human, recombinant（1st I.S.） 97/562
Blood Coagulation Factor VII Concentrate（1st I.S.） 97/592
Leptin, Human, Recombinant 97/594
Interleukin-2 Soluble Receptor （human, rDNA derived） 97/600
Leptin, Mouse, Recombinant 97/626
Somatropin 98/574
Calcitonin, Salmon 98/586
Blood Coagulation Factors II and X Concentrate（3rd I.S.） 98/590
Transforming Growth Factor beta-3 （Human, rDNA derived） 98/608
Fibrinogen, Plasma, Human, 2nd IS 98/612
Fibrinogen Concentrate, Human, 1st International Standard 98/614
Follicle Stimulating Hormone and Luteinizing Hormone, Human Urinary 98/704
Tissue Plasminogen Activator, Human, Recombinant 98/714
Neurotrophin 3 98/718
Biotinylated Brad-5 （Bio-Brad-5） 99/698
Anti-D Immunoglobulin Control 99/728
Biotinylated Brad-5 99/774
Thromboplastin,rabbit,plain（pack of 5 ampoules） with diluent （pack of 5 04/210） RBT/05
Thromboplastin, Human Recombinant, Plain （4th I.S.） （Panel of 5 ampoules for use with 5 diluent 08/146）. RTF/09


Diagnostics
Hepatitis A Virus RNA NAT Assays 00/560
Hepatitis B Surface Antigen （HBsAg） subtype adw2, genotype A 00/588
Hepatitis A Virus RNA Working Reagent for NAT assays 01/488
Anti-Toxoplasma IgG, Human 01/600
Anti-Parvovirus B19, plasma, human 01/602
HIV （antibody）, 1st International Reference Panel 02/210
Insulin-like growth Factor I 02/254
HCV RNA Working Reagent for Nucleic Acid Amplification Techniques 02/264-003
Protein C Plasma 02/342
HTLV-1 （antibody） Monitor Sample 03/104-009
Anti-HPA-1a standard 03/152
Anti-B minimum potency reference preparation 03/164
Vitamin B12, Serum Folate 03/178
Anti-A minimum potency reference preparation 03/188
Anti-HPA-3a（minimum potency） 03/190
Protein S, Plasma, Human 03/228
Hepatitis B Surface Antigen subtype adw2, genotype A Reference Panel 03/262
QCRHSV2QC1-Anti-HSV2 Quality Control Serum: Sample1 03/B346-06
Blood Coagulation Factor XI Plasma, Human（1st I.S.） 04/102
Plasmodium falciparum DNA for NAT Assays 04/176
Factor V Leiden, Human gDNA, 1st International Genetic Reference Panel 2004 04/224
Anti-HPA-1a minimum potency reagent 05/106
Anti-syphilis plasma IgG （human） 05/122
Prothrombin Mutation G20210A, Human gDNA, 1st International Genetic Reference Panel 2005 05/130
Anti-syphilis plasma IgG and IgM （human） 05/132
HIV-1 RNA Working Reagent 3 for NAT Assays 05/158-002
HLA-A Genotyping Reference Panel. 05/208-001
QCRTOXOQC1-Anti-Toxoplasma Quality Control Serum: Sample 1 05/B433-06
Hepatitis C Virus （HCV） RNA 06/100
Anti Hepatitis C Virus 06/188-006
Anti-HCV （1 in 8 dilution） 06/190-008
HPV 16 DNA 06/202
HPV 18 DNA 06/206
QCRHIV1QC5-Anti-HIV1: Quality Control Serum: Sample5 06/B461-04
QCRMALQC1-Anti-Malaria Quality Control Serum: Sample1 06/B475-06
Anti-HBs immunoglobulin 07/164
Recombinant soluble transferrin receptor （rsTfR）（1st WHO Reference Reagent） 07/202
Positive control for FCXM 07/214
RhD/SRY Plasma DNA sensitivity standard 07/222
Hepatitis B Surface Antigen Monitor Sample 07/286-006
Hepatitis B Surface Antigen 0.2IU/ml 07/288-004
Norovirus GII for Nucleic Acid Amplification Techniques 07/294-001
Influenza Virus （A/Christchurch/1/2003, H1N1） for Nucleic Acid Amplification Techniques 07/296-001
Influenza Virus （A/Wyoming/3/2003, H3N2） for Nucleic Acid Amplification Techniques 07/298-001
Influenza Virus （B/Jiangsu/10/2003） for Nucleic Acid Amplification Techniques 07/300-001
QCRHBclgMQC1-IgM Anti-HBc Quality Control Serum: Sample1 07/B498-08
QCRTHBcQC1-Total Anti-HBc Quality Control Serum: Sample1 07/B506-09
QCRTHBcQC1-Total Anti-HBc Quality Control Serum: Sample 1 07/B506-11
QCRTHBcQC2-Total Anti-HBc Quality Control Serum: Sample2 07/B512-06
QCRHBsQC1-Anti HBs Quality Control Serum: Sample1 07/B515-06
QCRHIV1P24QC1-HIV1 p24 Antigen: Quality Control Serum: Sample1 07/B519-12
Human Adenovirus serotype 2 for Nucleic Acid Amplification Techniques 08/114-001
Parainfluenza Virus serotype 3 for Nucleic Acid Amplification Techniques 08/118-001
Human Respiratory syncytial virus A2 for Nucleic Acid Amplification Techniques 08/120-001
HIV-2 RNA（1st International Standard） 08/150
Fragile X Syndrome gDNA Genetic Reference Panel 08/158
Haemophilia A, Intron-22 inversion, gDNA, Genetic Reference Panel 08/160
Human Coxsackie B4 for Nucleic Acid Amplification Techniques 08/174-001
Parainfluenza Virus serotype 1 for Nucleic Acid Amplification Techniques 08/176-001
Parainfluenza Virus serotype 2 for Nucleic Acid Amplification Techniques 08/178-001
Parainfluenza virus serotype 4 for Nucleic Acid Amplification Techniques 08/180-001
Thyroid Stimulating Antibody （2nd I.S.） 08/204
Human Herpes Simplex virus type 1 for Nucleic Acid Amplification Techniques 08/224-001
Human Herpes Simplex virus type 2 for Nucleic Acid Amplification Techniques 08/226-001
Antithrombin, Plasma （3rd International Standard） 08/258
C1 Inhibitor （Plasma）（1st International Standard） 08/262
HCV RNA Genotype Panel for Nucleic acid amplification techniques 08/264
Sex Hormone Binding Globulin. （2nd International Standard） 08/266
Varicella Zoster Virus （Type B） Working Reagent for Nucleic Acid Amplification Testing （NAT） 08/310-001
Human Cytomegalovirus for Nucleic Acid Amplification Techniques 08/314-002
Epstein-Barr Virus for Nucleic Acid Amplification Techniques 08/316-001
Human Norovirus GI Working Reagent for Nucleic Acid Amplification Testing 08/318-001
Human Metapneumovirus Working Reagent for Nucleic Acid Amplification Testing 08/320-001
Human Parechovirus Working Reagent for Nucleic Acid Amplification Testing 08/322-001
Human Rhinovirus Genogroup A Working Reagent for Nucleic Acid Amplification Testing 08/324-001
HIV-1RNA Genotype Panel 08/358
QCRRUBQC1-Anti-Rubella Quality Control Serum: Sample1 08/B523-03
QCRVZVQC1-AntiVZV: Quality Control Serum: Sample1 08/B531-06
QCRHIV2QC3-Anti HIV2: Quality Control Serum: Sample3 08/B534-03
QCRHIV1P24QC2-HIV1 p24 Antigen: Quality Control Serum: Sample2 08/B536-05
QCRHIV1QC1-Anti-HIV1:Quality Control Serum: Sample1 08/B538-04
QCRNEGQC1-Negative Quality Control Serum: Sample1 08/B539-06
QCRHCVQC1-Anti-HCV Quality Control Serum: Sample1 08/B542-06
QCRHIV2QC2-Anti HIV2:Quality Control Serum: Sample2 08/B544-06
QCRCMVQC1-Anti CMV: Quality Control Serum: Sample1 08/B549-06
QCRHBeQC1-Anti-HBe Quality Control Serum: sample1 08/B554-04
Parvovirus B19 DNA Nucleic Acid Amplification Technology（NAT） based assays Genotype Panel（1st International Standard） 09/110
Negative Control for FCXM 09/112
Human Coronavirus 229E Working Reagent for Nucleic Acid Amplification Testing 09/132-001
Genetic Reference Panel, for the quantitation of BCR-ABL translocation by RQ-PCR （1st I.S.） 09/138
Prader Willi & Angelman Syndromes, Human gDNA,（1st International Genetic Reference Panel） 09/140
Human Cytomegalovirus （HCMV） for Nucleic Acid Amplification Techniques （1st International Standard） 09/162
Blood coagulation Factors II, VII, IX, X Plasma （4th International Standard） 09/172
Neisseria meningitidis for Nucleic Acid Amplification Testing （NAT） 09/320-001
QCRSYPHQC2-Anti-Syphilis Quality Control Serum: sample2 09/B559-06
QCRHIV1QC3- Anti-HIV1:Quality Control Serum: Sample3 09/B562-01
QCRHBsGQC1-Anti HBsAg Quality Control Serum: Sample1 09/B564-02
QCRHBsGQC2-Anti HBsAg Quality Control Serum: Sample2 09/B566-01
QCRHIV1QC2- Anti-HIV 1: Quality Control Serum: Sample 2 09/B571-02
QCRHAVIgMQC2-Anti-HAV Quality Control Serum: Sample2 09/B572-05
QCRRUBQC1-Anti-Rubella Quality Control Serum: Sample1 09/B577-01
QCRTHAVQC1-Total Anti-HAV Quality Control Serum: Sample1 09/B584-01
QCRSYPHQC1-Anti-Syphilis Quality Control Serum: Sample 1 09/B585-03
QCRHBsQC1-Anti HBs Quality Control Serum: Sample1 09/B587-02
HBV DNA PCR Reference 10/194-001
Rheumatoid Arthritis Serum 64/002
Anti-Thyroglobulin Serum, Human 65/093
Long-acting Thyroid Stimulator, Human 65/122
Anti-Nuclear Factor Serum （Homogenous） Human 66/233
Insulin, Human 66/304
Anti-thyroid Microsome Serum, Human 66/387
Immunoglobulin D （IgD） Serum, Human 67/037
Immunoglobulins G, A, M Serum Human 67/086
Immunoglobulins G, A & M Serum Human 67/099
Primary Biliary Cirrhosis Serum, Human 67/183
Erythropoietin, Human, Urinary 67/343
Anti-Nucleolar Factor Plasma, Human 68/340
Autoimmune Antibody to Human Spermatazoa 69/065
Anti-D （Rho） Antibodies, Human 73/515
Placental Lactogen, Human 73/545
Carcinoembryonic Antigen （CEA）, Human 73/601
Serum Proteins （Other than Immunoglobulins） Human 74/520
Corticotrophin （ACTH）, Porcine 74/586
Serum Immunoglobulin E （IgE） Human 75/502
Cocksfoot Pollen Extract 75/506
Chorionic Gonadotrophin, Human, for Radioiodination 75/533
Chorionic Gonadotrophin beta, Human, for Radioiodination 75/535
Parathyroid Hormone, Human 75/549
Chorionic Gonadotrophin beta Subunit, Human 75/551
Chorionic Gonadotrophin alpha subunit, Human 75/569
Chorionic Gonadotrophin alpha Subunit, Human, for Radioiodination 76/508
Mannan （C. Albians） Purified 76/515
Anti-Birch Pollen Serum, Human 76/525
Anti-Cocksfoot Serum, Human 77/503
Anti-D Pteronyssinus Serum, Human 77/584
Mannan （C. Albicans） Purified 77/600
Twelve Grass Pollen Extract 77/616
Acarus Siro Extract 77/662
Glycyphagus destructor Extract 77/664
Tyrophagus Putrescentiae Extract 78/517
Anti-Aspergillus fumigatus Serum, Human 78/545
Aspergillus Fumigatus Extract 78/575
Tyrophagus Longior Extract 78/582
Bee Venom 78/628
Parathyroid Hormone, Human 79/500
Anti-Cat Fur Serum, Human 79/530
Thyroid Stimulating Hormone, Human 81/565
Dermatophagoides Pteronyssinus Extract 82/518
Timothy Pollen Extract 82/520
Human Serum Vitamin B12, Pernicous anaemia 82/652
C- Peptide of Human Insulin 84/510
Proinsulin, Bovine 84/514
Birch Pollen Extract 84/522
Proinsulin, Porcine 84/528
Short Ragweed Pollen Extract 84/581
Proinsulin, Human 84/611
Anti-c Serum, Human 84/628
Dog （Canis Familiaris） Hair Dander Extract 84/685
Thyroid Stimulating Hormone beta subunit 85/522
Anti-Rye Grass Serum, Human 85/551
Haemoglobin F Lysate, Raised 85/616
Anti-Ferritin Monoclonal Antibody （1） 87/654
Anti-Ferritin Monoclonal Antibody （2） 87/662
Thyroxine-binding globulin 88/638
Haemoglobin A2 Lysate, Raised 89/666
HIV-1 P24 Antigen 90/636
Anti-Varicella-Zoster Antibody 90/690
Anti-D for use with papain preparation 92/658 91/562
Papain preparation for use with Anti-D preparation 91/562 92/658
Insulin-like growth Factor Binding Protein-3 93/560
Ferritin, Human, recombinant 94/572
Follicle Stimulating Hormone/Luteinizing Hormone, Human Pituitary 94/632
Thyroid Stimulating Hormone, Human recombinant 94/674
Anti-HBc （Anti-hepatitis B core antigen） 95/522
Folate, Whole Blood 95/528
Anti-hepatitis E Serum, Human 95/584
Parathyroid Hormone 1-84, human, recombinant（1st International Standard） 95/646
Lupus Anticoagulant Negative Control 96/522
Anti-Human Globulin 96/666
Prostate Specific Antigen （free） 96/668
Prostate Specific Antigen （90:10） 96/670
Islet Cell Antibodies 97/550
Anti-Hepatitis A Immunoglobulin, Human （W1041） 97/646
HIV-1 RNA, 2nd International Standard 97/650
Prolactin, Human, recombinant 97/714
Hepatitis B Virus DNA for nucleic acid amplification techniques 97/750
Prolactin Human, recombinant, glycosylated 98/580
Prolactin, Human, recombinant, non-glycosylated 98/582
Haemiglobincyanide 98/708
HIV-1 RNA Working Reagent 1 （PWS-1） for NAT Assays 99/634-005
HIV-1 RNA Working Reagent 2 for NAT assays 99/636-005
Chorionic Gonadotrophin, nicked, human 99/642
Chorionic Gonadotrophin, beta subunit, human 99/650
Anti-HPA-5b （Minimum Potency） 99/666
HIV-2 （antibody） Monitor Sample 99/674-010
Chorionic Gonadatrophin, intact, Human 99/688
Chorionic Gonadotrophin, nicked beta subunit, Human 99/692
Chorionic Gonadatrophin, beta core fragment, Human 99/708
HIV-1 （antibody） （1 in 5 dilution） British Working Standard 99/710-012
Chorionic Gonadotrophin, alpha subunit, Human （purified） 99/720
Multiplex Working Reagent （HCV, HBV, HAV, HIV, B19） 99/732
Parvovirus B19 DNA Working reagent 99/736
HIV-1 （antibody） British Working Standard） 99/750-013
B19 DNA NAT assays.2nd I.S. 99/802
Anti-D Minimum Potency Standard for blood grouping reagents 99/836
Alpha-Foetoprotein AFP
Beta-2 Microglobulin B2M
Anti-Canine Distemper Serum CDS
Cholera Antitoxin, Goat CHAN
Anti-Canine Hepatitis Serum CHS
Anti-Dysentery （shiga） serum, Equine DY
Anti-Echinococcus Serum, Human ECHS
Anti-Mycoplasma gallisepticum Serum MGDS
Anti-Newcastle Disease Serum NDS
Anti-Q Fever Serum, Bovine QF
Anti-rabies Immunoglobulin, Human RAI
Swine Erysipelas Serum （anti-N） SES
Anti-Swine Fever Serum SFS
Anti-Salmonella Pullorum Serum （Std. Form S） SPDS-S2
Anti-Salmonella Pullorum Serum （Variant Form V） SPDS-V
Anti-tick borne encephalitis serum TILI
Anti-tick borne encephalitis serum TISA
Anti-C complete blood typing serum,human W1004
Anti-E complete blood typing serum, human W1005
Anti-c Incomplete blood typing serum, human W1007
Anti-Varicella zoster immunoglobulin W1044
Anti smooth muscle（anti actin） autoantibody. W1062
Anti nuclear ribonucleoprotein（nRNP） autoantibody W1063
Anti-Nuclear factor serum,homogenous（66/233） W1064
Rheumatoid Arthritis serum. W1066


Vaccines
MAPREC assay of poliovirus type 1 （Sabin）.100% 480-A, 525-C DNA（1st International Reference Preparation） 00/410
MAPREC assay of poliovirus type 1 （Sabin） Low Mutant Virus Reference（1st International Reference Preparation） 00/416
MAPREC assay of poliovirus type 1 （Sabin） （1st International Standard） 00/418
MAPREC assay of poliovirus type 1 （Sabin） High Mutant Virus Reference（1st International Reference Preparation） 00/422
Influenza anti A/Singapore/1/57 Serum （sheep） H2 00/440
Influenza anti B/Yamanashi/166/98 Serum （sheep） 00/442
Diphtheria Antitoxin Human Serum 00/496
Botulinum Antitoxin Human 00/500
Influenza Virus infectious B/Sichuan/379/99 00/530
Influenza Virus infectious B/Johannesburg/5/99 00/532
Influenza anti A/Chick/Scotland/59 （H5N1） Serum （sheep） 00/542
Influenza Virus infectious B/Victoria/504/00 00/544
Influenza Antigen B/Johannesburg/5/99 00/546
Influenza Antigen A/duck/Singapore/97 （H5N3） 00/552
Influenza anti B/Johannesburg/5/99/ Serum （sheep） 00/556
Influenza Virus infectious B/Guangdong/120/00 00/614
Anti-Meningococcal immunotype L3,7,9 mAb 01/412
Meningococcal group Y polysaccharide 01/426
Meningococcal group W135 polysaccharide 01/428
Influenza anti B/Guangdong/120/2000 Serum （sheep） 01/450
Influenza anti A/Panama/2007/99 Serum （sheep） 01/452
Botulinum Antitoxin Equine Type F 01/506
Botulinum Antitoxin Equine Type C 01/508
Botulinum Antitoxin Equine Type G 01/512
Anti-Meningococcal Serosubtype P1.7 mAb 01/514
Oral Poliovaccine Sabin Reference Preparation Type 1[LS-c, 2ab strain] 01/528
Oral Poliovaccine Sabin Reference Preparation Type 2 01/530
Oral Poliovaccine Sabin Reference Preparation Type 3 01/532
Anti-Meningococcal Serosubtype P1.16 mAb 01/538
Influenza Antigen B/Guangdong/120/2000 01/546
Influenza Virus infectious B/Hawaii/10/01 01/612
Influenza Antigen A/New Caledonia/20/99 01/614
Influenza anti A/Panama/2007/99 Serum （sheep） 02/102
Anti-Meningococcal Serosubtype P1.15 mAb 02/144
Anti-Meningococcal Serosubtype P1.4 mAb 02/148
Diphtheria Toxoid for use in Flocculation Test. 02/176
Anti-Meningococcal Serosubtype P1.2 mAb 02/178
Anti-Meningococcal Serotype P2.2a mAb 02/180
Anti-Japanese Encephalitis Virus Plasma, Human 02/182
Anti-Japanese Encephalitis （Anti-JE） Virus Control Plasma, Human 02/184
Anti-Dengue Virus Types 1+2+3+4, Human 02/186
Haemophilus influenzae b PRP 02/208
Tetanus Toxoid Not Adsorbed 02/232
Influenza Virus infectious B/Brisbane/32/2002 02/262
Influenza anti A/chick/Italy/13474/99 （H7N1） Serum （sheep） 02/294
Polio Virus Sabin Types 1, 2 and 3 02/306
Anti-Meningococcal Serotype P3.4 mAb 02/308
Anti-Meningococcal Serotype P3.15 mAb 02/310
Botulinum Antitoxin Equine Type E 02/318
Anti-Meningococcal Serosubtype P1.3 mAb 02/320
Influenza Antigen A/New Caledonia/20/99 02/336
Influenza anti A/Panama/2007/99 Serum （sheep） 02/338
Influenza anti B/Shangdong/9/97 Serum （sheep） 03/110
Anti-Meningococcal Serosutype P1.1 mAb 03/114
Anti-Meningococcal Serosubtype P1.14 mAb 03/142
Anti-Meningococcal Serotype P3.21 mAb 03/182
Influenza Virus infectious A/Kumamoto/102/02 03/198
Anti-Meningiococcal Serosubtype P1.6 mAb 03/210
Influenza anti A/Wyoming/03/03 Serum 03/212
Influenza Antigen A/Wyoming/03/03 03/220
Anti-Meningococcal Serosubtype P1.10 mAb 03/224
Anti-Meningococcal Serosubtype P1.5 mAb 03/226
Anti-Meningococcal Serosubtype P1.13 mAb 03/236
Influenza anti A/Puerto Rico/8/34 （H1N1） HA Serum 03/242
Influenza anti A/chick/Germany/N/49 （H10N7） HA Serum （sheep） 03/244
Influenza Antigen A/New Caledonia/20/99 （IVR-116） 03/258
Anti-Meningococcal Serosubtype P1.12 mAb 04/122
Tetanus Toxoid For Flocculation Test 04/150
Influenza Virus infectious NYMC X-147 04/160
Influenza Virus infectious A/Wellington/1/2004 04/170
Influenza Virus infectious IVR-139 04/172
Anti-Meningococcal Serotype P3.1 mAb 04/198
Influenza Antigen B/ Jiangsu/10/2003 04/202
Influenza anti A/Vietnam/1194/04 （NIBRG-14） HA Serum （sheep SH440&SH442） 04/214
Influenza anti B/ Neuraminidase Serum 04/228
Influenza anti N1 Neuraminidase Serum 04/230
Influenza anti B/Jiangsu/10/2003 HA Serum （sheep） 04/242
Anti-Meningococcal Serogroup W-135 mAb 04/246
Anti-Meningococcal Serosubtype P1.19 mAb 04/248
Influenza Virus infectious A/New York/55/2004 04/254
Influenza anti N2 Neuraminidase Serum（prepared from A/Wyoming/3/2003） 04/258
Influenza anti A/New Caledonia/20/99 HA Serum （sheep） 04/260
Influenza anti A/New York/55/2004 HA Serum （sheep） 04/262
Influenza Antigen A/New York/55/2004 （H3N2） （NYMC X-157） 04/264
Influenza Virus infectious NYMC BX-7 05/102
Influenza Virus infectious A/California/7/2004 05/110
Anti-human papillomavirus type 16 serum （1st International Standard） 05/134
Influenza Virus infectious B/Shanghai/361/2002 05/138
Anti Meningococcal Serosubtype P1.9 Monoclonal Antibody 05/190
Anti Meningococcal Serotype P2.2b Monoclonal Antibody 05/192
Influenza Virus infectious A/Hiroshima/52/2005 05/232
Influenza Antigen A/Wisconsin/67/2005 - Like 05/234
Influenza anti A/Wisconsin/67/2005 Serum （sheep） 05/236
Influenza Virus infectious NYMC X-161 05/244
Anti Dengue, WHO Reference Panel 05/248
Influenza anti B Neuraminidase Serum （Sheep SH463） 05/252
Influenza Antigen A/Wisconsin/67/2005 （H3N2） （NYMCX-161） 06/106
Influenza Virus infectious IVR-116 06/108
Influenza Virus Infectious A/PR/8/34 06/114
Monoclonal Antibody for Serotyping Bordela pertussis Fimbrial Antigen 2 （1st International Standard） 06/124
Monoclonal Antibody for Serotyping Bordela pertussis Fimbrial Antigen 3 （1st International Standard） 06/128
Pertussis Antiserum （human）1st IS - WHO international Standard. 06/140
Pertussis Antiserum （Human） 1st WHO Reference Reagent 06/142
Influenza Virus infectious 1 VR-142 06/164
Influenza Antigen A/New Caledonia/20/99 06/170
Influenza Virus infectious A/Wisconsin/67/2005 06/184
Influenza anti A/turkey/Turkey/1/05 （NIBRG-23） HA serum（sheepSH465 & SH466） 06/192
Medium Titre Meningococcal OMV Ref. serum 06/210
Influenza Virus infectious A/Solomon Islands/3/2006 07/132 06/236
Influenza Virus infectious NYMC-X161 B 06/242
Influenza Antigen A/Solomon Islands/3/2006 （IVR-145）（H1N1） 07/102
Influenza anti A/Solomon Islands/3/2006 （H1N1） （IVR-145） HA Serum （sheep 467,468,469,470） 07/104
Influenza Antigen A/turkey/Turkey/1/2005 （H5N1） NIBRG-23 07/112
Influenza Virus infectious B/Malaysia/2506/2004 07/132
Influenza Virus infectious IVR-145, 07/144
Influenza anti A/HongKong/1073/99 like HA Serum （sheep） 07/146
Influenza anti A/Vietnam/1194/04 （H5N1） HA Serum 07/148
Human Plasma Anti-Influenza H5N1 07/150
Rabies vaccine 07/162
Influenza anti B/Malaysia/2506/2004-HA Serum （sheep） 07/184
Diphtheria Toxoid （Adsorbed） （4th International Standard） 07/216
Influenza Virus Infectious A/New Caledonia/20/99 07/226
Influenza Virus Infectious IVR-147 07/246
Influenza Virus infectious NIBRG-14 07/252
Influenza Virus Infectious B/Brisbane/3/2007 07/268
BCG Vaccine of Danish 1331 sub-strain （1st WHO Reference Reagent） 07/270
BCG Vaccine of Tokyo 172 sub-strain（1st WHO Reference Reagent） 07/272
BCG Vaccine of Russian BCG-I sub-strain（1st WHO Reference Reagent） 07/274
Influenza anti A/mallard/Netherlands/12/2000 （H7） HA serum （NIBRG-60） （sheep SH474 AND SH475） 07/278
Influenza Antigen A/Anhui/1/05 （H5N1） IBCDC-RG-6 07/290
Meningococcal Group C Polysaccharide 07/318
Influenza Antigen A/mallard/Netherlands/12/00 （H7N3） NIBRG-60 07/336
Influenza anti A/Anhui/1/05 （H5） HA serum （IBCDC-RG6） （Sheep SH477） 07/338
Influenza Virus infectious NYMC X-171B 07/348
Influenza Virus infectious A/Uruguay/716/2007 07/354
Influenza Anti-B/Florida/4/2006 HA serum （sheep 478, 479） 07/356
Influenza Virus infectious NIB-50 07/358
Influenza Virus infectious IVR-149 07/362
Influenza Antigen A/Brisbane/59/2007 （IVR-148） （H1N1） 08/100
Influenza Virus Infectious NIBRG-91 08/108
Influenza Virus Infectious NIBRG-88 08/110
Influenza anti A/turkey/Turkey/1/05（N1） NA Serum （NIBRG-74） （Sheep SH485） 08/126
Influenza Virus Infectious B/Florida/4/2006 08/138
Influenza Antigen B/Florida/4/2006 08/140
Influenza anti A/Anhui/1/05 （H5） HA serum （IBCDC-RG6） （sheep SH477） 08/142
Influenza Virus Infectious NIBRG-12 08/154
Influenza Virus Infectious NIBRG-23 30060 VE3 08/156
Influenza Antigen B/Malaysia/2506/2004 08/184
Influenza anti A/chick/Hong Kong/G9/1997/（H9） HA serum （NIBRG-94）（H9N1） 08/202
Influenza Antigen Hong Kong/1073/99 （H9N2） 08/208
Influenza anti A/Cambodia/R0405050/2007 （H5） HA serum （NIBRG-86） 08/210
Influenza Antigen A/Cambodia/R0405050/2007 （H5N1） NIBRG-88 08/216
Tetanus Toxoid Adsorbed （4th International Standard） 08/218
Influenza Antigen A/chick/Hong Kong/G9/1997 （H9N2） NIBRG-91 08/228
Influenza anti A/Brisbane/10/2007- like HA serum 08/246
Influenza Antigen A/mallard/England/727/2006 （H2N3） NIBRG-107 08/268
Influenza Antigen A/Brisbane/10/2007-like （Prepared from A/Uruguay/716/2007 （NYMC X-175C）） 08/278
Influenza Virus Infectious B/Brisbane/33/2008 08/280
Influenza Virus Infectious IVR-148 08/300
Influenza virus infectious NYMC X-175C 08/304
Influenza Antigen B/Brisbane/60/2008-like 08/352
Influenza anti A/Japan/305/57 （H2） HA serum （A/Singapore/1/57-Like） （Sheep SH398） 08/356
Influenza Virus Infectious BX-31 08/360
Influenza Antigen A/New York/107/2003 （H7N2） NIBRG-109 08/362
Influenza Virus Infectious NIB-58 08/364
Influenza anti A/mallard/England/727/2006 （N3） NA serum （NIBRG-107） （Sheep SH503） 09/100
Influenza Virus Infectious NIBRG-122 09/130
Influenza Antigen A/California/7/2009 （H1N1）v （NYMC-179A） （Egg derived） 09/146
Clostridium Sordellii anti-serum （1st International standard） 09/154
Influenza Virus Infectious B/Brisbane/60/2008 09/168
Anti-Meningococcal factor H binding protein variant 1 （JAR4） monoclonal antibody 09/170
Influenza Antigen A/California/7/09 （H1N1）v （NYMCX-179A） （Cell Derived） 09/174
Influenza Antigen A/Vietnam/1194/2004 （H5N1） NIBRG-14 09/184
Influenza Antibody （human） to A/California/7/2009 "like" （H1N1v） （1st International Standard） 09/194
Influenza Antigen A/California/7/2009 （H1N1v） （NIBRG-121xp） （Egg Derived） 09/196
Diphtheria Antitoxin Equine DI 09 10 iu/ml 09/204
Influenza Virus Infectious A/Perth/16/2009 09/208
Influenza Virus Infectious NYMC X-179A 09/216
Influenza Virus Infectious IVR-153 09/236
Influenza Virus Infectious NYMC X-183 09/248
Influenza Virus Infectious NIBRG-121xp 09/268
Influenza Virus Infectious NYMC X-185 09/274
Influenza Virus Infectious A/Brisbane/59/2007 09/276
Influenza Virus Infectious NIB-64 09/280
Influenza Virus Infectious NYMC X-187 09/290
Influenza Antigen A/California/7/09 （H1N1）v （NYMC-181） （Egg Derived） 09/294
Influenza Virus Infectious IVR-155 09/304
Influenza Virus Infectious NIBRG-147 09/306
Influenza Antigen A/Wisconsin/15/09 （H3N2） （NYMCX-183） 09/310
Influenza Virus Infectious NYMC X-181 09/314
Influenza Anti B Neuraminidase Serum （B/Florida/4/2006） 09/316
Influenza Virus Infectious NYMC BX-35 09/318
Influenza Antigen A/Victoria/210/09 （H3N2） （NYMCX-187） 10/102
Influenza Antigen B/Brisbane/60/2008 Reassortant （NYMC BX-35） 10/106
Influenza Antiserum A/Brisbane/59/2007 （H1N1）（IVR-148） HA （sheep 516 and 517） 10/120
Influenza Virus Infectious A/California/7/2009 10/122
Diphtheria Polyclonal Antibody 10/128
Diphtheria Monoclonal Antibody 10/130
Tetanus Polyclonal Antibody 10/132
Tetanus Monoclonal Antibody 10/134
Influenza Anti-B/Brisbane/60/2008 HA serum 10/146
Influenza Anti-A/Perth/16/2009 HA Serum 10/182
Influenza Anti A/Hong Kong 1073/99 （N2）NA Serum （Sheep SH395 SH396） 10/214
Influenza Virus Infectious NIB-74 10/216
Influenza Anti A/California/7/2009 （N1） NA Serum （Sheep SH 521） 10/218
Influenza Virus Infectious IVR-158 10/226
Influenza Anti-A/California/7/2009 （H1N1） HA Serum 10/230
Influenza virus infectious B/Brisbane/60/2008 30990 E6 10/244
Clostridium Perfringens Beta Antitoxin 2CPBETAAT
Clostridium Perfringens Epsilon Antitoxin 2CPEPSILONAT
Gas Gangrene （Cl. Perfringens（Cl. Welchii） Type A）, Equine 59/015
Botulinum Antitoxin Equine Type A 59/021
Botulinum Antitoxin Equine Type B 60/001
Tetanus Antitoxin, Equine, for Bioassay 60/013
Botulinum Antitoxin Equine Type D 61/001
Gas Gangrene Antitoxin （Cl. Histolyticum）, Equine 63/005
Diphtheria Antitoxin, Equine, for Flocculation Test 63/007
Gas Gangrene Antitoxin （Cl. Septicum）, Equine 64/014
Gas Gangrene Antitoxin （Cl. Oedematiens）, Equine 64/024
Tetanus Antitoxin, Equine, for Flocculation Test 66/021
Diphtheria Antitoxin, Equine 66/153
Anti-Rubella Serum, Human 67/182
Diphtheria Toxoid, Plain 69/017
Cholera Vaccine （Inaba） 73/554
Opacity 5IRP 76/522
Influenza anti A/Victoria/3/75 Serum（goat） 76/547
Tetanus Antitoxin, Human, Immunoglobulin 76/589
Influenza Antigen A/New Jersey/8/76 77/530
Influenza anti A/New Jersey/8/76 （H1N1） Serum（sheep） 77/531
Influenza anti B/Hong Kong/8/73 Serum（sheep） 77/568
Influenza Antigen A/Texas/1/77 78/560
Influenza anti A/Texas/1/77 Serum （sheep） 78/569
Influenza anti A/Brazil/11/78 Serum （goat） 79/516
Influenza Antigen A/USSR/92/77 79/552
Influenza Antigen A/USSR/92/77 79/558
Influenza Antigen A/Brazil/11/78 79/560
Influenza Antigen B/Hong Kong/8/73 79/568
Influenza Antigen A/Bangkok/1/79 80/517
Influenza Antigen B/Singapore/222/79 80/519
Influenza anti B/Singapore/222/79 Serum 80/523
Influenza anti A/Bangkok/1/79 Serum （sheep） 80/525
Anti Poliovirus serum types 1,2 and 3 82/585
Influenza Antigen A/Philippines/2/82 83/537
Influenza anti A/Philippine/2/82 Serum （sheep） 83/545
Influenza Antigen A/Brazil/11/78 83/550
Influenza Antigen A/Chile/1/83 84/538
Influenza Antigen B/Norway/1/84 84/542
Influenza anti B/USSR/100/83 Serum（sheep） 84/636
Influenza anti A/Chile/1/8 Serum（sheep） 84/640
Influenza anti A/equine/Prague/56 （H7N7） Serum（goat） 84/673
Influenza anti A/equine/Miami/63 （H3N8） Serum（goat） 84/677
Influenza anti A/Equine/Kentucky/1/81 HA Serum （sheep） 85/516
Influenza Antigen A/Equine/Kentucky/1/81 85/520
Influenza Antigen A/Equine/Prague/56 （H7N7） 85/553
Influenza Antigen A/Mississippi/1/85 86/576
Influenza anti A/Mississippi/1/85 Serum（sheep） 86/590
Influenza anti B/Ann Arbor/1/86/HA Serum （sheep） 86/592
Influenza Antigen B/Ann Arbor/1/86 86/630
Influenza Antigen A/Equine/Miami/63 87/510
Influenza anti A/Leningrad/360/86 Serum （sheep） 87/578
Influenza Antigen A/Leningrad/360/86 87/584
Influenza Antigen A/Sichuan/2/87 87/714
Influenza Antigen B/Victoria/2/87 87/774
Bordela pertussis （Whole cell vaccine） 3BRP 88/522
Influenza Antigen B/Beijing/7/87 88/554
Influenza Antigen A/England/427/88 88/654
Influenza anti A/Sichuan/2/87 Serum（sheep） 88/672
Influenza anti B/Beijing/1/87 Serum（sheep） 88/678
Influenza anti A/England/427/88 Serum（sheep） 88/846
Anti-Bordela pertussis serum （Human） 89/530
Influenza Antigen A/OMS/5389/88 89/568
Bordela pertussis （W28） LPS 2ug 89/594
Bordela pertussis anti-agglutinogen 1（rabbit） 89/596
Bordela pertussis anti-agglutinogen 2 （rabbit） 89/598
Bordela pertussis anti-agglutinogen 3 （rabbit） 89/600
Bordela pertussis （W28） LPS25ug 89/670
Influenza Antigen A/Shanghai/16/89 90/500
Influenza Antigen A/Guizhou/54/89 90/502
Influenza anti A/Guangdong/39/89 Serum（sheep） 90/504
Bordela Pertussis toxin （PT） 90/518
Bordela pertussis, filamentous haemagglutinin （FHA） 90/520
Mumps Vaccine （Live） 90/534
Bordela pertussis 69kD 90/654
Influenza Virus infectious NIB-26 （H3N2） 90/784
Poliomyelitis Vaccine （Inactivated） 91/574
Influenza anti A/Taiwan/1/86 Serum （sheep） 91/612
Influenza Virus infectious A/Texas/36/91 （H1N1） 91/660
Influenza Virus infectious NIB-27 （H1N1） 91/670
Rubella Vaccine （Live） 91/688
Influenza Antigen A/Texas/36/91 92/530
Influenza anti B/Yamagata/16/88 Serum（sheep） 92/582
Influenza Antigen B/Yamagata/16/88 92/628
Influenza anti A/Beijing/352/89 （H3N2） Serum （sheep） 92/632
Measles Vaccine （Live） 92/648
Influenza Virus infectious A/Beijing/32/92 （H3N2） 92/734
Influenza Virus infectious A/Shanghai/24/90 92/738
Influenza Antigen A/Beijing/32/92 93/500
Influenza Antigen A/Shanghai/24/90 93/516
Influenza anti A/Beijing/32/92 （H3N2） Serum （sheep） 93/518
Influenza anti A/Shanghai/24/90 （H3N2） Serum （sheep） 93/522
Influenza Virus infectious A/Beijing/359/89 （H3N2） 93/568
Influenza Virus infectious A/Guizhou/54/89 （H3N2） 93/572
Influenza Virus infectious A/Shangdong/9/93 （H3N2） 93/686
Influenza Virus infectious B/Panama/45/90 93/692
Influenza Virus infectious A/Harbin/15/92 （H3N2） 93/816
Influenza Antigen B/Panama/45/90 94/500
Influenza anti A/Shanghai/9/93 Serum（sheep） 94/504
Influenza Antigen A/Shangdong/9/93 94/516
Influenza anti B/Panama/45/90 Serum（sheep） 94/520
Pertussis Vaccine Whole Cell 94/532
Influenza Virus infectious A/Johannesburg/33/94 （H3N2） 94/758
Influenza Virus infectious B/Beijing/184/93 94/760
Influenza Virus infectious RESVIR-8 （H3N2） 94/762
Influenza Virus infectious NIB-34 （H3N2） 94/766
MAPREC analysis of Poliovirus type 3 （Sabin）. Synthetic DNA 100% 472-C 94/790
Hepatitis A Vaccine, inactivated 95/500
Influenza Antigen A/Texas/36/91 95/510
Influenza Antigen A/Johannesburg/33/94 95/516
Influenza anti A/Johannesburg/33/94 Serum（sheep） 95/524
Influenza anti A/Taiwan/1/86 Serum （H1N1） 95/536
MAPREC analysis of Poliovirus type 3 （Sabin） Synthetic DNA 0.9% 472-C 95/542
Anti-Meningococcal Serogroup A mAb 95/674
Anti-Meningococcal Serogroup C mAb 95/678
Anti-Meningococcal Serogroup B mAb 95/750
Influenza Virus infectious A/Wuhan/359/95 （H3N2） 95/758
Anti-Hib Human Reference Serum 96/536
MAPREC analysis of Poliovirus type 3 （Sabin） Low virus reference 0.7%472-C 96/572
MAPREC analysis of Poliovirus type 3 （Sabin） High virus reference 1.1%472-C 96/578
Influenza Virus infectious A/Bayern/7/95 96/830
Influenza Virus infectious RESVIR-9 （H3N2） 96/836
Influenza Virus infectious A/Shenzhen/227/95 （H1N1） 96/848
Influenza Virus infectious NIB-39 （H1N1） 96/850
Influenza Antigen A/Johannesburg/82/96 97/518
Bordela pertussis anti 69kD serum （sheep） 97/558
Bordela pertussis anti FHA serum （sheep） 97/564
Bordela pertussis PT anti serum （sheep） 97/572
Bordela pertussis anti Fim3 serum （sheep） 97/574
Influenza Antigen A/Equine/Newmarket/2/93 97/584
Influenza Antigen A/Equine/Newmarket/1/93 97/596
Influenza anti A/equine/Newmarket/1/93 Serum（sheep） 97/610
Influenza anti A/Nanchang/933/95 （H3N2） 97/612
Influenza anti A/Equine/Newmarket/2/93 （H3N8） HA Serum （SH-376） 97/614
Bordela pertussis anti serum （mouse） 1RR 97/642
Anti-Measles serum 97/648
AntiStreptolysin O 97/662
Influenza Virus infectious IVR-108 （H3N2） 97/692
Influenza Virus infectious A/duck/Sing-Q/119/97 （H5N3） 97/722
Influenza Virus infectious B/Harbin/7/94 97/726
Influenza Antigen B/Harbin/7/94 97/748
MAPREC analysis of Poliovirus type 2 （Sabin）, low virus reference 0.65%481-G 97/756
MAPREC analysis of Poliovirus type 2 （Sabin） Synthetic DNA 0.67%481-G 97/758
Influenza Antigen A/Beijing/262/95 97/760
MAPREC analysis of Poliovirus type 2 （Sabin） Synthetic DNA, 100%481-G 98/524
Influenza Virus infectious RESVIR-13 （H3N2） 98/544
Diphtheria and Tetanus Antitoxin, Guinea Pig Serum 98/572
MAPREC analysis of Poliovirus type 2 （Sabin）, high virus reference 1.21% 481-G 98/596
Influenza Virus infectious NIB-40 （H5N3） 98/600
Influenza anti B/Harbin/7/94/HA Serum （sheep） 98/604
Influenza Virus infectious ARIV-1 （H5N3） 98/610
Influenza anti A/Hong Kong/489/97 （H5N1） Serum （sheep） 98/666
Control Guinea Pig Serum 98/686
Meningococcal group A polysaccharide 98/722
Influenza Virus infectious Resvir-14 （H3N2） 98/762
Influenza anti A/Beijing/262/95 Serum （sheep） 98/772
Influenza Antigen B/Shangdong/7/97 98/774
Influenza Virus infectious A/Sichuan/346/98 （H3N2） 98/778
Anti-PT S1 subunit Monoclonal Antibody （1B7） 99/506
Anti-PT S1 subunit Monoclonal Antibody （1D7） 99/508
Anti-PT S1 subunit Monoclonal Antibody （3F11） 99/510
Anti-PT S1 subunit Monoclonal Antibody （10D6） 99/512
Anti-PT S1 subunit Monoclonal Antibody （8G4） 99/514
Anti-PT S1 subunit Monoclonal Antibody （E1E） 99/516
Anti-PT S1 subunit Monoclonal Antibody （E2E） 99/518
Anti-PT S1subunit Monoclonal Antibody （3F10） 99/520
Anti-PT S1 subunit Monoclonal Antibody （11D9） 99/522
Anti-PT S1 subunit Monoclonal Antibody （4D10） 99/524
Anti-PT S23 subunit Monoclonal Antibody （11E6） 99/526
Anti-PT S23 subunit Monoclonal Antibody （10C9） 99/528
Anti-PT S23 subunit Monoclonal Antibody （10B5） 99/530
Anti-PT S23 subunit Monoclonal Antibody （G9A） 99/532
Anti-PT S23 subunit Monoclonal Antibody （3F6） 99/534
Anti-PT S2 subunit Monoclonal Antibody （3A12） 99/536
Anti-PT S2 subunit Monoclonal Antibody （2H3） 99/538
Anti-PT S2 subunit Monoclonal Antibody （9G8） 99/540
Anti-PT S3 subunit Monoclonal Antibody （7E10） 99/542
Anti-PT S3 subunit Monoclonal Antibody （7G11） 99/544
Anti-PT S3 subunit Monoclonal Antibody （4G5） 99/546
Anti-PT S3 subunit Monoclonal Antibody （2E12） 99/548
Anti-PT S3 subunit Monoclonal Antibody （6F8） 99/550
Anti-PT S4 subunit Monoclonal Antibody （7F2） 99/554
Anti-PT S4 subunit Monoclonal Antibody （6B3） 99/556
Anti-PT S4 subunit Monoclonal Antibody （6G8） 99/558
Anti-PT S4 subunit Monoclonal Antibody （9F3） 99/560
Anti-PT S4 subunit Monoclonal Antibody （1H2） 99/562
Anti-PT S4 subunit Monoclonal Antibody （9C6） 99/564
Anti-PT S4 subunit Monoclonal Antibody （6D6） 99/566
Anti-PT S5 subunit Monoclonal Antibody （7E3） 99/568
Anti Filamentous Haemagglutinin Monoclonal Antibody （1C6） 99/570
Anti-Filamentous haemagglutinin Monoclonal Antibody （2E9） 99/572
Anti Filamentous Haemagglutinin Monoclonal Antibody （12G10） 99/574
Influenza Antigen B/Yamanashi/166/98 99/586
Methylated Human Serum Albumin （mHSA） 99/592
Influenza Antigen A/Sydney/5/97 99/614
Yellow Fever Vaccine 99/616
Influenza Antigen A/Sydney/5/97 99/624
Anti-Meningococcal human reference serum CDC1992 99/706
Influenza Antigen A/Singapore/1/57 （H2N2） 99/714
Influenza Virus infectious RESVIR 16 （H3N2） 99/824
Influenza Antigen B/Yamanashi/166/98 99/828
Botulinum Antitoxin Equine Type B BUSB
Clostridium novyi （alpha） Toxoid COT
Clostridium Welchii （Perfringens）（Beta） Toxoid CwBT CWBETATD
Clostridium Welchii （Perfringens）（ Epsilon） Toxoid CwDT CWEPSILONTD
Bordela pertussis anti FHA serum （mouse） JNIH-11
Bordela pertussis PT（ LPF） anti serum, （mouse） JNIH-12
Acellular Pertussis Vaccine - 1st IS JNIH-3
Bordela pertussis filamentous haemagglutinin （FHA） JNIH-4
Bordela pertussis toxin （PT） 1st IS JNIH-5
Newcastle Disease Vaccine （Inactivated） NVIA
Gas Gangrene Antitoxin （Cl. novyi）, Equine OE
Gas Gangrene Antitoxin （Cl. Perfringens alpha antitoxin） Equine PE
Purified Protein Derivative （PPD） of M Avium Tuberculin PPDA
Purified Protein Derivative （PPD） of Bovine Tuberculin PPDBOV
Purified Protein Derivative （PPD） of M. Tuberculosis Tuberculin PPDT
Anti-rubella Immunoglobulin, Human RUBI-1-94
Smallpox Vaccine SMV
Anti-Staphylococcal P-V Leucocidin serum, Equine SPLS
Staphylococcus Alpha Antitoxin, Equine STA
Diphtheria （Schick） Test Toxin STT
Tetanus Immunoglobulin, Human TE-3
Typhoid Vaccine （acetone-inactivated） TYVK
Typhoid Vaccine （heat-phenol-inactivated） TYVL
Gas Gangrene Antitoxin （Cl. Septicum）, Equine VI
Anti-Yellow Fever Serum, monkey YF